Abstract:Ewing sarcoma is a highly aggressive pediatric cancer driven by the EWS::FLI1 (EF) fusion oncogene. Evidence suggests that EF expression levels dictate tumor cell plasticity contributing to treatment resistance and relapse. Our study aims to elucidate the transcriptional programs and phenotypes associated with distinct EF thresholds. To dynamically fine-tune EF levels, we engineered Ewing sarcoma cell line models by C-terminally tagging endogenous EF with a fluorescent (mNG) and a degron tag (dTAG). Using mNG as a quantitative proxy for EF levels, we confirmed that increasing concentrations of the dTAG ligand led to a gradual loss of the fusion protein. Already subtle modulation of EF thresholds significantly enhanced tumor cell migration. Furthermore, a 25% EF reduction was sufficient to significantly lower anchorage-independent growth in soft agar, which was completely abolished with further EF depletion. Supported by zebrafish xenograft experiments, these findings suggest that minor EF fluctuations enhance migratory properties while still retaining significant in vitro tumor-forming potential. To characterize acute transcriptional responses to variations in EF thresholds, we performed SLAM-sequencing after 3 hours of treatment with increasing dTAG concentrations. While minor reduction of the fusion protein to 76% led to immediate downregulation of EF-activated genes enriched in GGAA microsatellites, most EF-repressed targets were upregulated only when EF levels were reduced by 58% to 96%. These de-repressed targets were significantly enriched for epithelial-to-mesenchymal transition (EMT)-related pathways. Testing EF chromatin occupancy by CUT&RUN followed by motif enrichment analysis, identified several transcription factor binding motifs linked to EF-repressed genes. Promising candidates include SP1, EGR1, and TFAP2A, all of which have previously been implicated in the regulation of metastasis-related pathways. Long-term dTAG treatment (1 to 3 weeks), followed by EF rescue through dTAG ligand washout for 7 days revealed a set of metastasis-related genes that notably remained upregulated despite a full recovery of EF levels already within 24 hours of ligand washout. This suggests that transient oncogene fluctuations may cause a sustained increase in metastatic potential of Ewing sarcoma cells. Importantly, about thirty of these genes negatively correlated with overall survival in a cohort of 196 Ewing sarcoma patients and were anti-correlated with the GGAA microsatellite-driven transcriptional repressor BCL11B, which was highly sensitive to minor changes in EF thresholds. Collectively, our results highlight the critical role of EF oncogene fluctuations in Ewing sarcoma cell plasticity and patient prognosis providing new insights into the gene regulatory mechanisms involved. Further, our findings have important implications for therapeutic approaches aiming at directly targeting EF. Understanding EF dynamics in Ewing sarcoma serves a paradigmatic approach to the identification of therapeutic vulnerabilities in fusion oncogene-driven cancers. Citation Format: Veveeyan Suresh, Christoph Hafemeister, Sarah Grissenberger, Caterina Sturtzel, Florencia Cidre Aranaz, Thomas Grünewald, Ana Sastre, Javier Alonso, Martin Distel, Florian Halbritter, Heinrich Kovar, Valerie Fock. Dynamic modelling of EWS::FLI1 fluctuations reveals molecular determinants of phenotypic tumor plasticity and prognosis in Ewing sarcoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl) nr A017.

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells

Influence of injury severity on the rate and magnitude of the T lymphocyte and neuronal response to facial nerve axotomy

GENE-04. THE ONCOGENIC FUNCTIONS OF YAP1-GENE FUSIONS CAN BE INHIBITED BY DISRUPTION OF YAP1-TEAD INTERACTION

Suppression of a "recurrent" idiotype results in profound alterations of the whole B-cell compartment.

Endogenous EWSR1-FLI1 degron alleles enable control of fusion oncoprotein expression in tumor cell lines and xenografts

Abstract 1467: A novel screening model to identify EWS::FLI1 regulators and their consequences on Ewing sarcoma plasticity

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma

Abstract A017 Dynamic modelling of EWS::FLI1 fluctuations reveals molecular determinants of phenotypic tumor plasticity and prognosis in Ewing sarcoma

YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells

Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility

History of the World Allergy Organization: A Global Scientific Meeting on Allergy Comes to Asia—The XX World Allergy Congress of Bangkok, Thailand, 2007

Transforming Properties of Yap, A Candidate Oncogene on the Chromosome 11q22 Amplicon

Abstract 87: EHD1 is required for IGF1R-mediated oncogenic signaling in Ewing Sarcoma

EWS-FLI1 employs an E2F switch to drive target gene expression

Current propagation between a plasma opening switch and a load during opening

YAP Modulates TGF-β1-induced Simultaneous Apoptosis and EMT Through Upregulation of the EGF Receptor

YAP Silencing by RB1 Mutation is Essential for Small-Cell Lung Cancer Metastasis

[Cheek pouch epithelial cell proliferation induced by DMBA application and incorporation of BrdU].

Attention mediated by synchrony of neurons

Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer